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An active and tetrameric form of recombinant butyrylcholinesterase (BChE), a large and
complex human enzyme, was produced via semicontinuous operation in a transgenic rice
cell suspension culture. After transformation of rice callus and screening of transformants,
the cultures were scaled up from culture flask to a lab scale bioreactor. The bioreactor
was operated through two phases each of growth and expression. The cells were able to
produce BChE during both expression phases, with a maximum yield of 1.6 mg BChE/L
of culture during the second expression phase. Cells successfully regrew during a 5-day
growth phase. A combination of activity assays and Western blot analysis indicated
production of an active and fully assembled tetramer of BChE.
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INTRODUCTION
Butyrylcholinesterase (BChE, EC 3.1.1.8) is a native human serine hydrolase enzyme that has been
shown to function as a bioscavenger against various organophosphorus nerve agents, with both
prophylactic and therapeutic applications (Lenz et al., 2005). BChE is a complex tetrameric protein
comprised of four identical 85 kDa monomers, each with 9 N-linked glycosylation sites (Lockridge,
2015). BChE can be purified from expired human blood plasma, but low yields and high costs
(anticipated >US$10,000 per treatment dose) limit its use (DARPA, 2012). Therefore, there is a
pressing need for a cost-effective platform for recombinant production of BChE.
Recombinant BChE has been successfully produced in several expression systems, including
transgenic goats and mice (Huang et al., 2007), insect cells (Brazzolotto et al., 2012), transgenic
plants (Geyer et al., 2010), transient expression in plants (Schneider et al., 2014a), and CHO
cells (Ilyushin et al., 2013; Terekhov et al., 2015). However, a major limitation in the production
of recombinant BChE is the need to produce tetrameric BChE, which has a significantly longer
circulatory half-life than the dimeric or monomeric forms (Duysen et al., 2002). Many of these
systems show incomplete tetramerization of the molecule (Huang et al., 2007; Geyer et al., 2010;
Brazzolotto et al., 2012; Schneider et al., 2014b). While there has been success with production of
fully tetrameric BChE in CHO cells through coexpression of the enzyme with a proline-rich peptide
(Terekhov et al., 2015), mammalian systems are susceptible to contamination with mammalian
pathogens and require extensive regulatory clearances for human therapeutic use. Whole plant
systems can avoid this problem, but also require specialized facilities to grow and harvest transgenic
material or to transiently express foreign proteins.
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Plant cell suspension cultures, however, offermany advantages
over alternative expression systems for the production of
human therapeutics. These include (1) a simple, low cost,
animal component-free, chemically-defined medium; (2) lack
of susceptibility to contamination with mammalian pathogens;
and (3) the ability to perform complex post-translational
modifications such as glycosylation (Huang and McDonald,
2012). Unlike with whole plant systems, plant cell cultures can
make use of already existing cell culture infrastructure. Thus,
a plant cell suspension culture is well suited to address the
difficulties associated with production of BChE.
In particular, the use of the rice alpha amylase 3D (RAmy3D)
expression system in a rice cell suspension culture enables
efficient, high-level expression of foreign proteins (Huang et al.,
2001). The RAmy3D system contains an inducible promoter that
is activated by sugar starvation and a signal peptide that tags the
protein for secretion into the culture medium. This allows for a
cyclical or semicontinuous operation of the culture in which the
cells are subjected to multiple phases of growth and expression
by alternating between a sugar-rich and sugar-free medium. In
addition, use of an inducible expression system may alleviate
some of the problems associated with reduced productivity over
long culture times that has been observed for plant cell cultures
that utilize constitutive expression systems (Raven et al., 2015).
Semicontinuous operation can further reduce culture costs by
eliminating the shut down and start up time between runs
that would be necessary in a batch culture system. Although
RAmy3D has been successfully used for the production of other
recombinant proteins in rice cell culture (Huang et al., 2002;
Trexler et al., 2005; Park et al., 2010), it has not been used to
produce a molecule as large and complex as BChE.
To address the need for effective, scalable, and active BChE,
we have designed and studied a transgenic rice cell suspension
culture for the production of BChE using the RAmy3D
expression system. This study demonstrates semicontinuous
bioreactor production of an active form of BChE, which with
continued development, can provide a reliable system for
production of this molecule as a therapeutic or prophylactic.
MATERIALS AND METHODS
Expression Vector Design and Cloning
The native human BChE (NCBI NM_000055) coding sequence
without the native secretion signal peptide was modified for
expression in rice and inserted into a vector (pUC57) containing
the RAmy3D promoter, signal peptide, and terminator sequences
using GenScript (GenScript, Piscataway, NJ). The native human
BChE coding sequence was codon optimized for expression
in rice and analyzed using Visual Gene Developer (http://
visualgenedeveloper.net). The sequence was modified without
any changes in the amino acid sequence of the mature protein.
The overall GC content of the DNA sequence was increased from
40.2 to 51.4%, and the codon adaptation index was changed from
0.68 to 0.83. The final construct was then cloned in a binary
vector (pCAMBIA2300) and incorporated via heat shock into
Agrobacterium tumefaciens strain EHA 105 for transformation.
Transformation and Selection of Callus
The transformation was performed as described in Huang et al.
(2001) with minor modifications. Callus derived from seeds of
Oryza sativa cv. Taipei 309 were co-cultivated withA. tumefaciens
containing the described vector at OD600 = 1.0 for 20min. The
callus was transferred to semi-solid medium and incubated in the
dark at 25◦C for 3 days before washing three times with a solution
of 200mg/L timentin and 250mg/L cefotaxime. Finally, the callus
was transferred to a sucrose (S) rich semi-solid selection medium
(“NB”) that contains N6 macronutrients (Chih-Ching et al.,
1975), B5 micronutrients and vitamins (Gamborg et al., 1968),
2mg/L 2,4-dicholorophenoxyacetic acid (2,4-D), 250mg/L L-
proline, 250mg/L L-glutamine, 300mg/L casein hydrolysate,
30 g/L sucrose, 1.8 g/L gelzan, and 50mg/L geneticin as the
selection antibiotic, denoted as NB+S. Previous studies show that
supplementation with proline and glutamine promotes callus
induction (Pawar et al., 2015).
Screening of Transformed Callus
Transformed callus was subjected to eight rounds of screening
at increasingly larger scales in selection media containing
geneticin (as the selection antibiotic). The first round of screening
evaluated 310 transformation events and was performed in a 96
well plate. Callus was transferred from semi-solid NB+S to a well
containing liquid NB+S (same composition as described above)
and stored in an Innova 4000 incubator/shaker (Eppendorf, Inc.,
Hauppauge, NY) at 60 rpm and 27◦C in the dark for 5 days.
Induction was performed by sterilely pipetting off the spent
NB+S medium and replacing it with an equal volume of NB−S
medium, which has the same composition as NB+S except that
the sucrose (S) is replaced with 8 g/L mannitol. Samples of both
the spent medium and biomass were collected and analyzed at
120 h after induction. After the fourth round of screening, the
top 10 transformation events were used to establish shake flask
cultures. Flasks with nominal volumes between 125mL and 1 L
were filled to 1/5 full and maintained at 140 rpm and 27◦C in
the dark in the same incubator/shaker. Flask screenings were
performed in the same manner as well plate screenings. After
the 8th round of screening, a single, top-performing cell line
was selected based on cell physiology (healthy appearance, light
color, friable aggregates) and BChE expression stability, and
suspension cultures of this line were maintained through weekly
sub-culturing with fresh liquid NB+S medium.
Bioreactor Operation
Cultures were scaled up for operation in a 5 L bioreactor (BioFlo
3000, Eppendorf, Inc., Hauppauge, NY) equipped with a single
pitched blade impeller. To obtain small and consistently sized
aggregates, cultures were sieved at the time of inoculation by
pressing the biomass through a 280 µm pore size stainless steel
mesh sieve (Sigma Aldrich, St. Louis, MO).
The bioreactor was operated under conditions similar to those
described in Trexler et al. (2002) with slight modifications. The
bioreactor was maintained at 27◦C, 75 rpm (agitation speed),
and 40% (air saturation) dissolved oxygen (Mettler Toledo O2
sensor). The dissolved oxygen level in the culture was controlled
by altering the concentration of oxygen, nitrogen, and air in the
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gas sparging stream, and the overall gas flow rate was maintained
between 0.2 and 0.4 vvm. The oxygen uptake rate was determined
by measuring the change in dissolved oxygen in the culture in the
absence of aeration. The pH of the culture was monitored but not
controlled. The cultures were grown under ambient light, and the
conditions were identical for both growth and expression phases.
Induction of BChE expression in the bioreactor was
performed using gravity sedimentation. After the biomass was
allowed to settle, a peristaltic pump and sterile tube welder were
used to remove the spent NB+Smedium and replace it with fresh
NB−S medium. For semicontinuous operation, another growth
phase was initiated by following the same procedure described
above, by removing the NB−Smedium and replacing with NB+S
medium.
Biomass Measurements
Four well-mixed 10mL samples were taken every 24 h (48 h
during the initial growth period) from the reactor under sterile
conditions through the sampling port. One sample was set aside
for protein extraction and quantification, and the remaining
three were used to determine the fresh weight (FW) and dry
weight (DW) of cells by washing them in 10mL double distilled
water (to remove residual sugars) on a pre-weighed 1.6 µm
Binder-Free Glass Microfiber filter (Whatman GF/A 4.7 cm,
GE Healthcare Life Sciences, Pittsburgh, PA). The combined
filter and biomass was weighed immediately to obtain the FW,
then dried in an oven at 65◦C for 24 h and weighed again to
obtain the DW.
Sugar Analysis
The concentrations of sucrose and glucose in the culture medium
were measured using YSI 2900 Biochemistry Analyzer (Xylem,
Inc., Rye Brook, NY). Cell-free medium from reactor sampling
was passed through a 0.22 µm syringe filter to remove any
remaining cells and stored at 4◦C until analysis. The YSI 2900
enzymatically measures sucrose and glucose concentrations in a
given sample and can account for any interaction between the
signals from each. Samples were measured at 2X and 4X dilutions
with double distilled water to ensure concentrations of each sugar
were within the accurate detection range of the instrument.
Quantification of Active Intracellular BChE
Concentration of active BChE was measured separately in the
medium (by analyzing crude culture medium) and associated
with the cell mass (by analyzing the crude cell extract). The
cell extract was prepared by grinding the callus in a 1:1 ratio
in cold homogenization buffer (100mM sodium phosphate,
100mM NaCl, pH 7.4) using a Tissue Tearor (Biospec Products,
Bartlesville, OK) operated at maximum speed for 30 s. The
homogenized sample was then centrifuged a 14,000 g for 10min,
and the supernatant was saved in a new tube and stored at 4◦C
until analysis.
Active BChE concentration in each sample was measured
using a modified Ellman activity assay (Ellman et al., 1961).
The assay monitors the hydrolysis of butyrylthiocholine
in the presence of Ellman’s reagent in 100mM sodium
phosphate buffer, pH 7.4. This reaction was monitored using
a spectrophotometer (SpectraMax 340PC, Molecular Devices,
Sunnyvale, CA) to measure the absorbance at 405 nm over a
period of 3min at 25◦C. Samples were concentrated (with a
30 kDa ultrafiltration membrane) or diluted to fall within the
accurate detection range of 0.5–1.0 ng BChE/µL sample. Once
the concentration of BChE from a sample was determined, it
was normalized to the mass of fresh weight biomass, volume of
extraction buffer, or volume of total culture.
Quantification of Total Soluble Protein
The total soluble protein (TSP) in a sample was measured using
a Bio-Rad Protein Assay kit (Bio-Rad, Hercules, CA), which is
based on the method of Bradford (Bradford, 1976). The assay
was performed per manufacturer’s instructions. Each sample
was analyzed in triplicate, including protein standards used to
generate a standard curve.
Gel Electrophoresis and Immunoblotting
SDS-PAGE was performed using a 4–15% gradient gel, and
native-PAGE using a 7.5% gel (Mini-PROTEAN precast gels,
BioRad, Hercules, CA). Western blotting was performed using a
1:200 dilution of mouse anti-BChE IgG as the primary antibody
and a 1:2000 dilution of goat anti-mouse IgG-HRP as the
secondary antibody (Santa Cruz Biotechnology, Dallas, TX),
and developed by incubation with 3,3′,5,5′-tetramethylbenzidine
(TMB) substrate. PEGylated recombinant human BChE derived
from transgenic goats (PharmAthene, Inc, Annapolis, MD) and
native equine serum BChE (Sigma Aldrich, St. Louis, MO) were
used as controls.
RESULTS
Transformation and Screening
The rice-optimized BChE gene construct was cloned into the
RAmy3D (Huang et al., 2001) expression system (Figure 1)
and subsequently into A. tumefaciens for gene delivery by co-
cultivation. Stable integration of incoming recombinant DNA
into cellular DNA is largely a random process, and accordingly,
the sites of integration are dispersed throughout the genome.
The ability to backcross and screen independent transgenic
events can produce more stable arrangements and expression
of the transgene in whole plants (Chih-Ching et al., 1975; Park
et al., 2010). For transgenic cell lines, however, the process is
more complex. Although primary calli can be selected for a
particular antibiotic resistance and screen for the expression of
a particular recombinant protein, genetic and epigenetic changes
that occur during multiple cycles of cell differentiation and
dedifferentiation can produce somaclonal variation in the calli
(Gamborg et al., 1968). These somaclonal variants can exhibit
a wide range of morphological and physiological phenotypes,
including variations in the expression of the transgene.
To meet our goal for stable protein expression over many
generations of microcalli propagation, extensive screening was
performed to identify the lines that provide optimal protein
production. Over 1000 transformants, from 310 independent
transformation events were initially selected and grown on
semi-solid selection medium. Of these, 105 events produced a
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detectable amount of BChE, with varying levels of expression
(data not shown). Figure 2 shows the combined amounts of
active secreted and cell-associated BChE from the top 20
transformation events during the first screening. After 8 rounds
of screening, one cell line (identified as line “9–2”) was selected
based on the expression stability and cell-line physiology for
continued development and scale up, and was used for all
remaining analyses described in this study.
Cell Growth, Oxygen Uptake, Sugar
Consumption, and BChE Expression
Kinetics
The semicontinuous bioreactor culture was operated for 31
days and underwent two cycles each of growth and expression.
Figure 3A shows the growth of the biomass over the duration
of the culture. The first growth phase (Growth 1) had an initial
biomass concentration of 0.21 ± 0.07 g DW/L of culture and
lasted 16 days, while the second growth phase (Growth 2) had an
initial biomass concentration of 2.37 ± 0.06 g DW/L and lasted
5 days. Growth 1 exhibited a long lag phase of 4 days followed
by a long exponential phase of 12 days prior to induction,
while Growth 2 had a lag of <1 day and a 5 day exponential
phase. This difference is likely due to the difference in the
initial biomass concentration during each growth phase. During
each expression phase, where NB+S was removed and replaced
with NB−S, the biomass concentration immediately dropped as
some of the biomass was pumped out of the reactor along with
the spent medium. However, at the beginning of expression,
the biomass concentration increased as the cells received fresh
medium components such as nutrients and amino acids. The
biomass concentration soon leveled off and began to drop as the
cells starved from sugar deprivation, until a new growth phase
was initiated. Table 1 summarizes the cell growth kinetics for
both growth phases. The maximum specific growth rate (µmax)
increased from 0.15 ± 0.01 day−1 during Growth 1 to 0.22 ±
0.01 day−1 during Growth 2, which correlated to a decrease in
doubling time from 4.7± 0.3 to 3.2± 0.1 days.
The oxygen uptake rate (OUR) of the culture was also
measured throughout operation as an indicator of the culture’s
metabolic activity (Figure 3B). A rise in OUR correlates with cell
growth, and a drop correlates with the onset of the stationary
phase. Our previous studies with Nicotiana benthamiana cell
culture showed that the maximum value of OUR correlated with
late exponential phase, and induction at this stage can lead to
higher expression of a heterologous target protein (Huang et al.,
2010). Thus, each expression phase was initiated as the OUR
began to level off during the growth phase. However, the OUR
reached a maximum 1 day after induction in both expression
phases, and this may be explained in the same way as the initial
rise in biomass concentration. After this initial rise, the OUR
fell as the cells starved, until a new growth phase was initiated.
FIGURE 1 | A schematic representation of the expression vector for butyrylcholinesterase (BChE) under control of the rice alpha amylase 3D
expression cassette. RAmy3D P, rice alpha-amylase 3D promoter; RAmy3D SP, rice alpha-amylase signal peptide; BChE, codon optimized synthetic human BChE
gene; RAmy3D T, rice alpha-amylase terminator.
FIGURE 2 | Amount of active butyrylcholinesterase (BChE) normalized to the mass of fresh weight callus in the culture medium and associated with
the biomass during the initial screening for cell line selection. Data are shown for the 20 transformation events that produced highest amount of total active
BChE out of 310 total transformation events screened. The top transformation event chosen for scale up and further study (line “9–2”) has been labeled.
Frontiers in Plant Science | www.frontiersin.org 4 March 2016 | Volume 7 | Article 412
Corbin et al. Butyrylcholinesterase from Rice Cell Cultures
TABLE 1 | Biomass growth and oxygen consumption kinetic parameters for two growth phases.
Phases µmax(day−1) τD(days) Maximum OUR [mmol O2/(L·h)] Maximum specific OUR [mmol O2/(g DW·h)]
Growth 1 0.15 ± 0.01 4.7 ± 0.34 0.524 ± 0.003 0.294 ± 0.046
Growth 2 0.22 ± 0.01 3.2 ± 0.12 1.251 ± 0.012 0.179 ± 0.015
Key: µmax , maximum specific growth rate; τD, doubling time; OUR, oxygen uptake rate; DW, dry weight of callus.
FIGURE 3 | Rice cell culture kinetics through two phases of cell growth
and expression (as described in Section Materials and Methods) in a 5
L bioreactor. (A) Concentration of biomass in the culture in g of dry weight
(DW) callus per L of total culture. (B) Oxygen uptake rate (OUR) of the culture
in mmol O2 per L of culture per hour. (C) Concentration of glucose and
sucrose found in the culture medium in g/L. (D) Total active cell-associated
butyrylcholinesterase (BChE) in µg, normalized to g of fresh weight (FW) callus.
Table 1 shows that maximum OUR increased from 0.52mmol
O2/(L·h) in Growth 1 to 1.25mmol O2/(L·h) in Growth 2, which
is expected because this value does not account for the increase in
biomass density. The maximum specific OUR actually decreases
from 0.29mmol O2/(g DW·h) in Growth 1 to 0.18mmol O2/(g
DW·h) in Growth 2.
During growth phases, the sucrose concentration gradually
decreased as it was hydrolyzed to produce equal concentrations
of glucose and fructose, which can be consumed by the cells.
Throughout the culture operation, the rate of hydrolysis of
sucrose was faster than the rate of glucose consumption, which
can be seen as a gradual decrease in sucrose concentration and
increase in glucose concentration during both growth phases
(Figure 3C). Both growth phases displayed the same trend, but
Growth 2 showed the pattern on a shorter time scale, which is
likely due to the increased biomass density. At the beginning
of both expression phases, the sugar rich (+S) medium is
removed and replaced with sugar free medium (−S), causing the
concentration of both sugars to drop to and remain at 0 g/L for
the duration of the expression phase.
Active BChE concentration rose gradually over time during
each expression phase (Figure 3D). The first expression phase
(Expression 1) produced a maximum active BChE concentration
of 21.4 ± 2.3 µg/g FW biomass, while the second expression
phase (Expression 2) produced a maximum of 25.2 ± 1.9 µg/g
FW biomass. Expression 1 had a lag time between induction and
expression of about 2 days, and reached its maximum expression
level 4 days after induction. During Growth 2, the concentration
of BChE decreased gradually until it was no longer detectable.
Expression 2 had a lag of <1 day, and reached a peak around
4 days after induction. These differences may be caused by
differences in the timing of induction, the culture density, and
the physiological condition of the cells. During both expression
phases, the majority of BChE produced was associated with the
cell mass. Negligible amounts of BChE were detected in the
medium.
Table 2 summarizes the kinetic parameters of BChE
expression. While the expression level on a per weight basis was
similar for both expression phases (21.4 and 25.2 µg/g FW),
the increased biomass density during Expression 2 lead to a
much higher amount of BChE produced per liter of culture
(an increase from 0.72mg/L culture during Expression 1 to
1.64mg/L in Expression 2). Expression 2 also had a much higher
maximum volumetric productivity (based on the cycle duration
including growth and expression phases) due to the absence of a
long growth lag phase and increased biomass density in Growth
2 as compared to Growth 1. Finally, the ratio of BChE to TSP
increased from the first to second expression phase; this may be
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due to improved adaptation during subsequent induction cycles
which resulted in increased expression of BChE.
Electrophoresis and Immunoblotting
Figure 4A shows aWestern blot under reducing conditions of the
cell-associated BChE from samples obtained during Expression
1 and Growth 2. Equal volumes (20 µL) of crude cell extract
were loaded into each lane. These extracts were obtained by
grinding cells in a 1:1 ratio of biomass to buffer, so the intensity
of the BChE band corresponds to the concentration of BChE
associated with the cells at the time each sample was taken. Under
reducing conditions, a distinct band is seen around 85 kDa,
which corresponds to the predicted size of a monomer of BChE.
Samples taken immediately before and after induction and 2
days after induction (lanes 1–3) show no visible band, which
corresponds to the low BChE activity as seen in the activity
data shown in Figure 3D (<5 µg/g FW). The band in lane 4
corresponds to a higher value of BChE activity (21 µg/g FW).
However, while we see a decrease in BChE activity from day 20
to 21 (a drop from 21 to 18 µg/g FW), there is an increase in
the intensity of the BChE band seen in the Western blot in lanes
5 and 6 (which correspond to samples taken immediately before
and after initiation of Growth 2 on day 21). Thismay indicate that
a portion of the BChE detected in the Western blot is inactive.
To determine the oligomerization status of the rice cell
culture-produced BChE, we performed Western blot analysis
under native conditions on a crude cell extract from Expression
1 (Figure 4B). Lane 2 contains 200 ng of purified equine serum
BChE (as human BChE has been commercially unavailable for
over a year), which is about 440 kDa in its tetrameric form. The
cell extract shows two bands, one smaller and one larger than
the equine control. The smaller product is near the expected
size of tetrameric BChE (340 kDa), while the other may be an
aggregation product.
DISCUSSION
The size and complexity of BChE has been a major impediment
in its production in any recombinant expression host. Despite
high expression levels (up to 5 g/L of milk), transgenic goats
are able to produce primarily dimeric BChE, which exhibits
a reduced circulatory half-life (∼2 min) in vivo (Huang et al.,
2007). Many attempts have been made to solve this problem,
including PEGylation (Sun et al., 2013) or sialylation (Ilyushin
et al., 2013) to increase this half-life, and addition of a proline-
rich peptide to encourage tetramerization (Larson et al., 2014;
Terekhov et al., 2015). Recent work by Schneider et al. also
reports difficulty in secretion of BChE oligomers produced by
transient expression in N. benthamiana, despite the molecule’s
ability to tetramerize in a crude cell extract (Schneider et al.,
2014b). Recombinant tetrameric BChE has been produced
in other cell culture types and reached up to 70mg/L of
culture (Terekhov et al., 2015), but these cultures have been
limited by a comparatively high cost of culture operation
and increased potential for contamination from human
pathogens.
Previous work by our group has demonstrated successful
semicontinuous production of a fully active alpha-1-antitrypsin
under control of the RAmy3D expression system in a transgenic
rice cell culture (Huang et al., 2001; Trexler et al., 2002, 2005).
In the current study, we successfully produced an intact and
active form of BChE, a larger and more complex glycoprotein
therapeutic. A maximum of 1.6mg/L of culture was produced
during the second expression phase in a relatively non-optimized
system. We expect that further refinements of the operational
strategy will increase expression levels to those of other cell
culture systems. For example, Park et al. have demonstrated a fed-
batch operational strategy, in which the culture is supplemented
with a concentrated solution of amino acids prior to sugar
depletion, that can enhanced product yields up to 1.8-fold
compared to induction via medium exchange (Park et al.,
2010).
One major advantage of our system is that we can produce
predominantly active and fully assembled tetrameric BChE.
This underscores the importance of this system as a safe and
cost-effective method for production of human biotherapeutics.
In addition to growing on an inexpensive culture medium,
long-term semicontinuous operation of the culture reduces the
need for long seed trains and minimizes turn-around time,
clean-in-place and steam-in-place operations, chemicals, and
energy. Furthermore, the regulatory pathway for plant-based
recombinant biologics for human therapeutic use has now been
established with the production and regulatory approval of
taliglucerase alfa (ElelysoTM) produced in carrot cell suspension
in batch culture for the treatment of Gaucher’s disease (Maxmen,
2012).
After the initial inoculation, the culture experienced a long
lag phase in cell growth. The process of sieving the callus
through a stainless steel mesh to obtain small cell aggregates
may be physically stressful for the cells, thus requiring a longer
initial growth period to acclimatize. This may be part of
the reason that Growth 2, which involved the same biomass
but no sieving immediately before the growth phase, did not
exhibit the same lag phase and reached a maximum OUR value
within 5 days. During expression phases, the culture reached a
maximum expression level of BChE around day 4 after induction.
Thus, after an initial acclimatization period, the culture can
operated by alternating between 5-day growth phases and 4-day
expression phases to maximize BChE productivity over longer
periods.
The negligible release of BChE in the culture medium during
bioreactor operation (in comparison to the screening stage,
where a significant portion of BChE was secreted into the
medium) may be due to the size of both the protein (340 kDa)
and the larger size of the cell aggregates in comparison to the
screening stage. For BChE to be released into the medium, BChE
must not only be secreted from the cell, but must also pass
through the cell wall and diffuse through the cell aggregate.
The tetrameric form of BChE is about 50–60 nm (Lockridge
et al., 2011), while the average pore size of the plant cell wall
is 35–50 nm (Carpita et al., 1979) in differentiated plant cells.
If tetrameric BChE is produced inside the cell and secreted in
its fully assembled form, the protein may be trapped inside
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the cell wall or within the aggregate and only released during
homogenization. Even if the tetramer is assembled after secretion,
the monomers or the fully assembled tetramer still must diffuse
through the cell aggregate to reach the culture medium. Because
early screening experiments were done at small scale, the
aggregates could be easily broken apart before expression level
studies. Here, as shown in Figure 2, we saw roughly 30–60%
of the total BChE secreted into the medium for most cell lines.
However, with each subsequent screening, we saw a reduction
in the proportion of BChE secreted into the medium. This can
be explained by the fact that each subsequent screening was
performed at an increasingly larger scale, which made it more
difficult to break apart large aggregates. These larger aggregates
provide a more challenging route through which secreted BChE
must diffuse into the culture medium, and can explain why the
proportion of secreted BChE dropped to nearly zero in later
cultures.
The issue of low secretion levels may be addressed by
decreasing the size of cell aggregates through alteration of
medium composition or operating parameters (particularly,
agitation, aeration rates, and length of growth and expression
phases). However, it is also possible that oligomeric BChE
is not able to correctly pass through the secretory pathway
completely, as has been seen in other plant systems (Schneider
et al., 2014b), and early screenings detected a small amount
of monomeric BChE that was able to secrete effectively.
To address this possibility, we are developing an alternate
semicontinuous operation format similar to that described
by Huang et al. (2010), in which a portion of the biomass
is harvested after an expression phase, while the remaining
biomass remains in the reactor as inoculum for the next growth
phase.
CONCLUSIONS AND FUTURE
PROSPECTS
Active recombinant BChE was produced in a transgenic rice cell
suspension culture using an inducible gene expression system.
Two complete phases of cell growth and BChE expression were
performed, and the cells were able to express milligram quantities
of active BChE during both expression phases and successfully
regrow during a growth phase. Theoretically, these cultures could
be operated indefinitely, and our goal is to evaluate the behavior
and productivity of the culture during long-term (several
months) operation, and if necessary by keeping a portion of the
cells as inoculum to the medium in subsequent cycles. Further
development of the culture and operation modes will aim to
increase the amount of BChE produced and secreted into the
culture medium, and to perform a more comprehensive
TABLE 2 | Maximum values of butyrylcholinesterase (BChE) expression kinetic parameters for two expression phases.
Phases BChE expression (µg/g FW) BChE expression (mg/L culture) Volumetric productivity (µg/L·day) Purity (% BChE/TSP)
Expression 1 21.4 ± 2.3 0.72 ± 0.16 35.8 ± 7.7 0.27 ± 0.02
Expression 2 25.2 ± 1.9 1.64 ± 0.15 183.8 ± 17.3 0.55 ± 0.03
Key: FW, fresh weight of callus; TSP, total soluble protein.
FIGURE 4 | Western blot analysis of butyrylcholinesterase (BChE) produced in rice cell culture. (A) Western blot under reducing conditions of
cell-associated samples from before and after medium exchanges. Each lane contains 20 µL of crude cell extract. Lane MW: molecular weight ladder; lane 1, day 16,
immediately before start of Expression phase 1; lane 2, day 16, immediately after start of Expression Phase 1; lane 3, day 18; lane 4, day 20; lane 5, day 21,
immediately before start of Growth phase 2; lane 6, day 21, immediately after start of Growth phase 2; lane 7, day 23; lane 8, day 25; lane 9, control, 900 ng purified
equine BChE. (B) Western blot under native conditions of BChE. Lane MW: molecular weight ladder; lane 1: 52 U (∼200 ng) active BChE from an intracellular sample
from day 3 of Expression phase 1; lane 2: control, 200 ng purified equine BChE.
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characterization of BChE, including determination of
the serum half-life and the glycosylation profile of the
product.
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